Joseph Stringer

Q: What is Joseph Stringer's success rate?

Joseph Stringer currently has a success rate of 74.8155573660315.

Q: What is the average return of Joseph Stringer's calls?

Their stock ratings have generated an average return of 31.831583490216477.

Needham | Healthcare

Joseph Stringer is an analyst from Needham specializing in the Healthcare sector. Ranked #1598 out of 4773 analysts, they have issued 35 stock ratings with a success rate of 74.82% and an average return of 31.83%.

Joseph Stringer has a well-established track record, with 35 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 74.82% and an average return of 31.83%, underscoring their expertise and ability to identify winning opportunities for investors.

#1598

Out of 4773

Total Ratings

+74.82%

Success Rate

+31.83%

Average Return

Recent Ratings Analysis

IONS

Buy

Sep 04, 2026

Target

$86.00

Current

$54.21

Performance

-6.68%

Joseph Stringer rated IONS as Buy on Sep 04, 2026, setting a price target of 86. The stock has underperformed, dropping 6.68% despite the bullish target of 86.

GILD

Buy

Aug 05, 2026

Target

$170.00

Current

$143.72

Performance

9.08%

On Aug 05, 2026, GILD was given a Buy rating by Joseph Stringer, with a target price of 170. The stock rallied 9.08% after the rating, narrowing the gap to the target of 170 and validating the bullish stance.

BIOA

Buy

Jul 31, 2026

Target

$35.00

Current

$8.49

Performance

-6.08%

BIOA received a Buy rating from Joseph Stringer on Jul 31, 2026, aiming for 35. The rating hasn’t played out as hoped, with the stock trading 6.08% below expectations.

PHAT

Buy

Jul 30, 2026

Target

$22.00

Current

$8.36

Performance

-7.42%

On Jul 30, 2026, Joseph Stringer published a Buy outlook on PHAT, with a target of 22. Market action contradicted the Buy thesis, as shares slipped to 8.36.

ALNY

Buy

Jul 30, 2026

Target

$357.00

Current

$248.68

Performance

21.02%

Joseph Stringer on Jul 30, 2026 assigned ALNY a Buy rating, with a price target of 357. The Buy call aligned well with market performance, producing a gain of 21.02%.

ANNX

Buy

Jul 15, 2026

Target

$25.00

Current

$3.94

Performance

-39.38%

On Jul 15, 2026, Joseph Stringer reaffirmed ANNX with a Buy rating, targeting 25. Shares slid 39.38% despite the recommendation, highlighting downside risks.

STTK

Buy

Jun 08, 2026

Target

$17.00

Current

$6.20

Performance

58.97%

STTK was rated Buy by Joseph Stringer on Jun 08, 2026, with a price objective of 17. A bullish response from the market helped close the gap of 10.80 to the target.

STOK

Buy

Mar 17, 2026

Target

$40.00

Current

$29.03

Performance

-11.68%

On Mar 17, 2026, Joseph Stringer initiated coverage on STOK with a Buy rating and target of 40. The Buy call has yet to be validated as shares remain 10.97 away from the target.

RYTM

Buy

Mar 17, 2026

Target

$130.00

Current

$104.71

Performance

19.42%

Joseph Stringer issued a Buy recommendation for RYTM on Mar 17, 2026, price target set at 130. Investors following the Buy call captured upside momentum, with shares now at 104.71.

VIR

Buy

Feb 24, 2026

Target

$18.00

Current

$10.62

Performance

11.91%

On Feb 24, 2026, VIR was evaluated by Joseph Stringer, who gave a Buy rating and target of 18. This case illustrates how a timely bullish rating can translate into tangible gains of 11.91%.

APLS

Buy

Jan 13, 2026

Target

$28.00

Current

$41.03

Performance

92.36%

Joseph Stringer rated APLS as Buy on Jan 13, 2026, setting a price target of 28. The call has proven timely, with shares rising 92.36% toward the price target of 28.

CDTX

Hold

Nov 14, 2025

Target

—

Current

$221.38

Performance

1.69%

On Nov 14, 2025, CDTX was given a Hold rating by Joseph Stringer, with a target price of null. Market indecision, reflected in sideways trading near 221.38, supported the cautious call.

RNA

Hold

Oct 27, 2025

Target

$65.00

Current

$10.36

Performance

-85.20%

RNA received a Hold rating from Joseph Stringer on Oct 27, 2025, aiming for 65. The Hold stance proved prudent, with the market softening by 85.20%.

MRNA

Hold

Oct 20, 2025

Target

—

Current

$143.97

Performance

428.52%

On Oct 20, 2025, Joseph Stringer published a Hold outlook on MRNA, with a target of null. The Hold call missed some of the bullish momentum as shares advanced toward null.

INZY

Buy

May 14, 2025

Target

$12.00

Current

$4.00

Performance

196.30%

Joseph Stringer on May 14, 2025 assigned INZY a Buy rating, with a price target of 12. The Buy call aligned well with market performance, producing a gain of 196.30%.

PCVX

Buy

Apr 08, 2025

Target

$90.00

Current

$59.47

Performance

96.92%

On Apr 08, 2025, Joseph Stringer reaffirmed PCVX with a Buy rating, targeting 90. The recommendation was supported by strong follow-through as the stock rose from 59.47 to 59.47.

LXRX

Hold

Mar 07, 2025

Target

—

Current

$2.00

Performance

410.46%

LXRX was rated Hold by Joseph Stringer on Mar 07, 2025, with a price objective of null. Despite caution, upside momentum rewarded risk-takers with gains to 2.

PLRX

Hold

Mar 04, 2025

Target

$10.00

Current

$1.17

Performance

-13.33%

On Mar 04, 2025, Joseph Stringer initiated coverage on PLRX with a Hold rating and target of 10. The rating matched the stock’s inability to hold above 1.17.

VRTX

Hold

Feb 11, 2025

Target

—

Current

$515.44

Performance

13.23%

Joseph Stringer issued a Hold recommendation for VRTX on Feb 11, 2025, price target set at null. A neutral call gave way to stronger-than-expected performance, closing in on null.

CARA

Buy

May 14, 2024

Target

$5.00

Current

$5.32

Performance

-79.57%

On May 14, 2024, CARA was evaluated by Joseph Stringer, who gave a Buy rating and target of 5. Investors saw limited payoff as shares fell short of the 5 target.

Frequency Asked Questions

Who is Joseph Stringer?

Joseph Stringer is an analyst from Needham specializing in the Healthcare sector.

What is Joseph Stringer's success rate?

Joseph Stringer currently has a success rate of +74.82%.

How many ratings has Joseph Stringer issued?

Joseph Stringer has issued 35 stock ratings so far.

What is the average return of Joseph Stringer's calls?

Their stock ratings have generated an average return of +31.83%.

What is Joseph Stringer's ranking?

Joseph Stringer is ranked #1598 out of 4773 analysts.

What types of ratings does Joseph Stringer give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Joseph Stringer?

You can follow Joseph Stringer by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Joseph Stringer?

Their latest rating was a Buy on IONS issued on 2026-09-04.